Navigation Links
Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
Date:9/15/2013

New York, NY (PRWEB) September 15, 2013

Nearly 1,500 Pradaxa lawsuits http://www.pradaxalawsuithelp.com/ filed on behalf of alleged victims of Pradaxa internal bleeding continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. According to court records, the litigation’s most recent Status Conference was convened on September 4, 2013, at which time the Court was provided with an update regarding the scheduling of depositions, as well as the status of certain discovery issues. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“Individuals continue to contact our Firm, after they or a loved one allegedly suffered a frightening episode of Pradaxa internal bleeding. We are pleased to see continued progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Bleeding Litigation
Pradaxa was approved in October 2010 to treat patients with atrial fibrillation, and was touted as an improvement over decades-old warfarin, a blood thinner sold under the brand name, Coumadin. However, according to a recent Bloomberg.com report, Pradaxa has been the subject of a number of safety alerts in the U.S. and abroad, most of which related to Pradaxa bleeding side effects. While warfarin bleeding can be stopped by the administration of vitamin k, there is no readily available antidote to stop Pradaxa internal bleeding .* In January, a study published by the Institute for Safe Medicine Practices reported that Pradaxa users who experience internal bleeding are 5 times more likely to die compared to those who suffer internal bleeding while using warfarin.

According to court documents, 1,495 Pradaxa lawsuits are pending in the Southern District of Illinois. All of the claims allege that Boehringer Ingelheim failed to provide adequate warnings regarding Pradaxa bleeding, particularly the lack of an antidote. The first bellwether trial in the Pradaxa litigation is scheduled to start in September 2014.

Alleged victims of Pradaxa bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Click Here to contact a Pradaxa lawyer at Bernstein Liebhard LLP. To arrange for a free legal consultation, please call 800-511-5092.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-internal-bleeding/prweb11123531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. DrugRisk Announces New Pradaxa Health Warning From Australia
8. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
9. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
10. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
11. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: